Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | John B. Henneman, III Age: 59 Director since September 2020 Independent Compensation Committee member Governance and Nominating Committee member 2020 Director Compensation: Fees earned or paid in cash $20,261, Stock awards $349,963, Total $370,224 |
| 2022-04-27 | John B. Henneman, III serves as Chair of the Compensation Committee and is a member of the Governance and Nominating Committee. He is an Independent Director. |
| 2023-05-01 | John B. Henneman, III - Director since September 2020, Committees: Compensation (Chair), Governance and Nominating, Capital Allocation, Age: 61. Compensation: $244,988 in 2022. |
| 2024-06-11 | John B. Henneman, III Age: 62 Chair of the Board Independent Committees: Compensation (Chair), Capital Allocation, Governance and Nominating Cash fees earned: $74,832 Stock awards: $174,980 Total: $249,812 |
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-27 | John B. Henneman, III Independent Director Age 61 Audit & Finance Committee member Compensation and Talent Development Committee member Compliance & Ethics Committee member |
| 2024-04-29 | Mr. Henneman was appointed as a director as of January 5, 2023. He has more than 25 years of combined financial and operational management experience in the life sciences industry. The Board believes that Mr. Henneman's senior management experience, his service on other boards of directors, and his extensive experience in finance, legal affairs, and mergers and acquisitions brings value to the Board. In 2023, Mr. Henneman received stock awards valued at $299,999 and cash fees of $55,417. |
Data sourced from SEC filings. Last updated: 2026-02-03